Marco Rusnati

Marco Rusnati

Brescia University

H-index: 62

North America-United States

About Marco Rusnati

Marco Rusnati, With an exceptional h-index of 62 and a recent h-index of 28 (since 2020), a distinguished researcher at Brescia University, specializes in the field of angiogenesis, virus infection, heparan sulfate proteoglycans, macromolecular interaction.

His recent articles reflect a diverse array of research interests and contributions to the field:

Validation of plasmonic-based biosensors for rapid and sensitive detection of rabbit hemorrhagic and foot-and-mouth disease viruses in biological samples

The role of heparin in spike SARS-CoV-2 infection: From a model for heparan sulfates to a starting structure for antivirals

Design, synthesis and biological evaluation of novel 2, 4-thiazolidinedione derivatives able to target the human BAG3 protein

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity

An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of …

Surface functionalization of extracellular vesicle nanoparticles with antibodies: A first study on the protein corona “variable”

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

Marco Rusnati Information

University

Position

Department of Molecular and Translational Medicine

Citations(all)

12569

Citations(since 2020)

2678

Cited By

10739

hIndex(all)

62

hIndex(since 2020)

28

i10Index(all)

136

i10Index(since 2020)

75

Email

University Profile Page

Brescia University

Google Scholar

View Google Scholar Profile

Marco Rusnati Skills & Research Interests

angiogenesis

virus infection

heparan sulfate proteoglycans

macromolecular interaction

Top articles of Marco Rusnati

Title

Journal

Author(s)

Publication Date

Validation of plasmonic-based biosensors for rapid and sensitive detection of rabbit hemorrhagic and foot-and-mouth disease viruses in biological samples

bioRxiv

Chiara Urbinati

Vittoria Di Giovanni

Giulia Pezzoni

Lorenzo Capucci

Marco Rusnati

2024

The role of heparin in spike SARS-CoV-2 infection: From a model for heparan sulfates to a starting structure for antivirals

Biophysical Journal

Giulia Paiardi

Maria Milanesi

Matheus Ferraz

Liv Zimmermann

Chiara Urbinati

...

2024/2/8

Design, synthesis and biological evaluation of novel 2, 4-thiazolidinedione derivatives able to target the human BAG3 protein

Future Journal of Pharmaceutical Sciences

Iten M Fawzy

Khairia M Youssef

Nasser SM Ismail

Joachim Gullbo

Khaled AM Abouzid

2015/6/1

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity

Journal of Chemical Information and Modeling

Lorenzo Guidetti

Alfonso Zappia

Laura Scalvini

Francesca Romana Ferrari

Carmine Giorgio

...

2023/11/1

An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of …

Pharmacological Research

Sergio Strizzi

Letizia Bernardo

Pasqualina D’Ursi

Chiara Urbinati

Andrea Bianco

...

2023/8/1

Surface functionalization of extracellular vesicle nanoparticles with antibodies: A first study on the protein corona “variable”

Nanoscale Advances

Angelo Musicò

Rossella Zenatelli

Miriam Romano

Andrea Zendrini

Silvia Alacqua

...

2023

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

International Journal of Molecular Sciences

Paola Fossa

Matteo Uggeri

Alessandro Orro

Chiara Urbinati

Alessandro Rondina

...

2022/10/14

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

Cancer Gene Therapy

Marco Rusnati

Giulia Paiardi

Chiara Tobia

Chiara Urbinati

Alessio Lodola

...

2022/7

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin

Cancer Gene Therapy

Marco Rusnati

Giulia Paiardi

Chiara Tobia

Chiara Urbinati

Alessio Lodola

...

2022/7

Prevention of Herpesviridae Infections by Cationic PEGylated Carbosilane Dendrimers

Pharmaceutics

Elena Royo-Rubio

Vanessa Martín-Cañadilla

Marco Rusnati

Maria Milanesi

Tania Lozano-Cruz

...

2022/2/28

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

Journal of Biological Chemistry

Giulia Paiardi

Stefan Richter

Pasqua Oreste

Chiara Urbinati

Marco Rusnati

...

2022/2/1

Metabolic soft spot and pharmacokinetics: Functionalization of C-3 position of an Eph–ephrin antagonist featuring a bile acid core as an effective strategy to obtain oral …

Pharmaceuticals

Francesca Ferlenghi

Carmine Giorgio

Matteo Incerti

Lorenzo Guidetti

Paola Chiodelli

...

2021/12/28

HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial …

Molecules

Chiara Urbinati

Maria Milanesi

Nicola Lauro

Cinzia Bertelli

Guido David

...

2021/12/10

A Bittersweet Computational journey among glycosaminoglycans

Giulia Paiardi

Maria Milanesi

Rebecca C Wade

Pasqualina D’Ursi

Marco Rusnati

2021/5/15

The FGF/FGFR system in the physiopathology of the prostate gland

Arianna Giacomini

Elisabetta Grillo

Sara Rezzola

Domenico Ribatti

Marco Rusnati

...

2021/4/1

In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library

European Journal of Medicinal Chemistry

Alessandro Orro

Matteo Uggeri

Marco Rusnati

Chiara Urbinati

Nicoletta Pedemonte

...

2021/3/5

Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays

European Journal of Medicinal Chemistry

Alice Parodi

Giada Righetti

Emanuela Pesce

Annalisa Salis

Bruno Tasso

...

2020/12/15

Recent strategic advances in CFTR drug discovery: an overview

Marco Rusnati

Pasqualina D’Ursi

Nicoletta Pedemonte

Chiara Urbinati

Robert C Ford

...

2020/3/31

Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties

European Journal of Medicinal Chemistry

Matteo Incerti

Simonetta Russo

Miriam Corrado

Carmine Giorgio

Vigilio Ballabeni

...

2020/3/1

See List of Professors in Marco Rusnati University(Brescia University)